|
1
|
Leung DY, Jain N and Leo HL: New concepts
in the pathogenesis of atopic dermatitis. Curr Opin Immunol.
15:634–638. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Leung DY and Bieber T: Atopic dermatitis.
Lancet. 361:151–160. 2003. View Article : Google Scholar
|
|
3
|
Choi EJ, Lee S, Hwang JS, Im SH, Jun CD,
Lee HS and Kim SH: DA-9601 suppresses 2,4-dinitrochlorobenzene and
dust mite extract-induced atopic dermatitis-like skin lesions. Int
Immunopharmacol. 11:1260–1264. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Furue M, Terao H, Rikihisa W, Urabe K,
Kinukawa N, Nose Y and Koga T: Clinical dose and adverse effects of
topical steroids in daily management of atopic dermatitis. Br J
Dermatol. 148:128–133. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Caramalho I, Lopes-Carvalho T, Ostler D,
Zelenay S, Haury M and Demengeot J: Regulatory T cells selectively
express toll-like receptors and are activated by
lipopolysaccharide. J Exp Med. 197:403–411. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yamamoto S, Kuramoto E, Shimada S and
Tokunaga T: In vivo augmentation of natural killer cell activity
and production of interferon-α/β and γ with deoxyribonucleic acid
fraction from Mycobacterium bovis BCG. Jpn J Cancer Res.
79:866–873. 1988.
|
|
7
|
Yamamoto S, Yamamoto T, Kataoka T,
Kuramoto E, Yano O and Tokunaga T: Unique palindromic sequences in
synthetic oligonucleotides are required to induce INF and augment
INF-mediated natural killer activity. J Immunol. 148:4072–4076.
1992.PubMed/NCBI
|
|
8
|
Fujieda S, Iho S, Kimura Y, Sunaga H,
Igawa H, Sugimoto C, Yamamoto S and Saito H: DNA from
Mycobacterium bovis bacillus Calmette-Guérin (MY-1) inhibits
immunoglobulin E production by human lymphocytes. Am J Respir Crit
Care Med. 160:2056–2061. 1999.
|
|
9
|
Zhu XL and Zhang Y: Pharmacological
property and clinical application progress of BCG-polysaccharide
nucleic acid. China Mod Med. 20:19–21. 2013.(In Chinese).
|
|
10
|
Fletcher CH and Crossgrove R; Institute
for Laboratory Animal Research. Guide for the Care and Use of
Laboratory Animals. 8th Edition. The National Acadamies Press;
Washington, DC: 2011
|
|
11
|
Kwon HK, Lee CG, So JS, Chae CS, Hwang JS,
Sahoo A, Nam JH, Rhee JH, Hwang KC and Im SH: Generation of
regulatory dendritic cells and CD4+Foxp3+T
cells by probiotics administration suppresses immune disorders.
Proc Natl Acad Sci USA. 107:2159–2164. 2010.PubMed/NCBI
|
|
12
|
Matsuda H, Watanabe N, Geba GP, Sperl J,
Tsudzuki M, Hiroi J, Matsumoto M, Ushio H, Saito S, Askenase PW and
Ra C: Development of atopic dermatitis-like skin lesion with IgE
hyperproduction in NC/Nga mice. Int Immunol. 9:461–466. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yuan XY, Ma HM, Li RZ, Wang RY, Liu W and
Guo JY: Topical application of aloperine improves
2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin
lesions in NC/Nga mice. Eur J Pharmacol. 658:263–269. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Perkins ND: Integrating cell-signalling
pathways with NF-κB and IKK function. Nat Rev Mol Cell Biol.
8:49–62. 2007.
|
|
15
|
Dong J, Jimi E, Zeiss C, Hayden MS and
Ghosh S: Constitutively active NF-κB triggers systemic TNF-α
dependent inflammation and localized TNF-α independent inflammatory
disease. Genes Dev. 24:1709–1717. 2010.
|
|
16
|
Galli SJ, Nakae S and Tsai M: Mast cells
in the development of adaptive immune responses. Nat Immunol.
6:135–142. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Galli SJ, Tsai M and Piliponsky AM: The
development of allergic inflammation. Nature. 454:445–454. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yanagisawa R, Takano H, Inoue K, Koike E,
Kamachi T, Sadakane K and Ichinose T: Titanium dioxide
nanoparticles aggravate atopic dermatitis-like skin esions in
NC/Nga mice. Exp Biol Med (Maywood). 234:314–322. 2009. View Article : Google Scholar
|
|
19
|
Matsuoka H, Maki N, Yoshida S, Arai M,
Wang J, Oikawa Y, Ikeda T, Hirota N, Nakagawa H and Ishii A: A
mouse model of the atopic eczema/dermatitis syndrome by repeated
application of a crude extract of house-dust mite Dermatophagoides
farinae. Allergy. 58:139–145. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim SH, Jun CD, Suk K, Choi BJ, Lim H,
Park S, Lee SH, Shin HY, Kim DK and Shin TY: Gallic acid inhibits
histamine release and proinflammatory cytokine production in mast
cells. Toxicol Sci. 91:123–131. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kang JS, Yoon WK, Han MH, Lee H, Lee CW,
Lee KH, Han SB, Lee K, Yang KH, Park SK and Kim HM: Inhibition of
atopic dermatitis by topical application of silymarin in NC/Nga
mice. Int Immunopharmacol. 8:1475–1480. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yamazaki F, Aragane Y, Maeda A, Matsushita
K, Ueno K, Yudate T, Kawada A and Tezuka T: Overactivation of
IL-4-induced activator protein-1 in atopic dermatitis. J Dermatol
Sci. 28:227–233. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Homey B, Steinhoff M, Ruzicka T and Leung
DYM: Cytokines and chemokines orchestrate atopic skin inflammation.
J Allergy Clin Immunol. 118:178–189. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kim HS, Kundu JK, Lee JS, Oh TY, Na HK and
Surh YJ: Chemopreventive effects of the standardized extract
(DA-9601) of Artemisia asiatica on azoxymethane-initiated
and dextran sulfate sodium-promoted mouse colon carcinogenesis.
Nutr Cancer. 60(Suppl 1): 90–97. 2008.PubMed/NCBI
|
|
25
|
Kim JY, Kim DY, Lee YS, Lee BK, Lee KH and
Ro JY: DA-9601, Artemisia asiatica herbal extract,
ameliorates airway inflammation of allergic asthma in mice. Mol
Cells. 22:104–112. 2006.
|
|
26
|
Suh WM, Park SB, Lee S, Kim HH, Suk K, Son
JH, Kwon TK, Choi HG, Lee SH and Kim SH: Suppression of
mast-cell-mediated allergic inflammation by Lindera
obtusiloba. Exp Biol Med (Maywood). 236:240–246. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li Q and Verma IM: NF-κB regulation in the
immune system. Nat Rev Immunol. 2:725–734. 2002.
|
